High-Content Screening for Cryptosporidium Drug Discovery

Area of Science:

• Parasitology
• Drug Discovery
• Cell Biology

Background:

• Cryptosporidiosis is a diarrheal disease caused by Cryptosporidium parasites.
• These obligate intracellular parasites require host cells for in vitro culture, complicating drug discovery.
• High-content screening (HCS) offers a powerful approach for phenotypic drug discovery in biologically relevant systems.

Purpose of the Study:

• To establish and validate a high-content imaging (HCI) assay for Cryptosporidium drug discovery.
• To enable phenotypic characterization of compounds targeting Cryptosporidium parasites.
• To facilitate large-scale screening of potential drug candidates.

Main Methods:

• Development of a 384- or 1536-well format HCI assay using infected HCT-8 human ileocecal adenocarcinoma cells.
• Utilizing HCS to combine multiple readouts for phenotypic screening.
• Application of the assay to assess compound efficacy against Cryptosporidium.

Main Results:

• The established HCI assay provides a robust platform for Cryptosporidium drug discovery.
• The assay allows for high-throughput screening of numerous compounds.
• Phenotypic characterization of known Cryptosporidium-active compounds is achievable.

Conclusions:

• High-content imaging assays are instrumental in advancing drug discovery for parasitic diseases like cryptosporidiosis.
• This HCI assay serves as a valuable tool for identifying and characterizing novel anti-cryptosporidial compounds.
• The developed assay supports efficient drug discovery pipelines for challenging intracellular pathogens.